[1] Yuan Q, Yu J, Wu X, Sun YR, Li ZQ, Du ZY, Wu XH, Hu J. Prognostic value of coagulation tests for in-hospital mortality in patients with traumatic brain injury[J]. Scand J Trauma Resusc Emerg Med, 2018, 26:3.
[2] de Oliveira Manoel AL, Neto AC, Veigas PV, Rizoli S.Traumatic brain injury associated coagulopathy[J]. Neurocrit Care, 2015, 22:34-44.
[3] Yuan Q, Sun YR, Wu X, Yu J, Li ZQ, Du ZY, Wu XH, Zhou LE, Hu J. Coagulopathy in traumatic brain injury and its correlation with progressive hemorrhagic injury:a systematic review and Meta-analysis[J]. J Neurotrauma, 2016, 33:1279-1291.
[4] Chen YK, Yan LJ, Fei LF, Liu FH, Xu Y, Huang MR. Analysis and prevention of adverse transfusion reactions from 2012 to 2014[J]. Zhongguo Shu Xue Za Zhi, 2015, 28:1504-1506.[陈月宽, 颜利江, 费良芬, 刘福慧, 徐艳, 黄美容. 176例输血不良反应的分析[J]. 中国输血杂志, 2015, 28:1504-1506.]
[5] Genét GF, Johansson PI, Meyer MA, Sølbeck S, Sørensen AM, Larsen CF, Welling KL, Windeløv NA, Rasmussen LS, Ostrowski SR. Trauma-induced coagulopathy:standard coagulation tests, biomarkers of coagulopathy, and endothelial damage in patients with traumatic brain injury[J]. J Neurotrauma, 2013, 30:301-306.
[6] Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI.Coagulation disorders after traumatic brain injury[J]. Acta Neurochir (Wien), 2008, 150:165-175.
[7] Epstein DS, Mitra B, Cameron PA, Fitzgerald M, Rosenfeld JV.Acute traumatic coagulopathy in the setting of isolated traumatic brain injury:definition, incidence and outcomes[J].Br J Neurosurg, 2015, 29:118-122.
[8] Maegele M. Coagulopathy after traumatic brain injury:incidence, pathogenesis, and treatment options[J]. Transfusion, 2013, 53:S28-37.
[9] Carney N, Totten AM, O'Reilly C, Ullman JS, Hawryluk GW, Bell MJ, Bratton SL, Chesnut R, Harris OA, Kissoon N, Rubiano AM, Shutter L, Tasker RC, Vavilala MS, Wilberger J, Wright DW, Ghajar J. Guidelines for the management of severe traumatic brain injury, fourth edition[J]. Neurosurgery, 2017, 80:6-15.
[10] Franschman G, Boer C, Andriessen TM, van der Naalt J, Horn J, Haitsma I, Jacobs B, Vos PE. Multicenter evaluation of the course of coagulopathy in patients with isolated traumatic brain injury:relation to ct characteristics and outcome[J]. J Neurotrauma, 2012, 29:128-136.
[11] Franschman G, Greuters S, Jansen WH, Posthuma LM, Peerdeman SM, Wattjes MP, Loer SA, Boer C. Haemostatic and cranial computed tomography characteristics in patients with acute and delayed coagulopathy after isolated traumatic brain injury[J]. Brain Inj, 2012, 26:1464-1471.
[12] Zhang J, Zhang F, Dong JF. Coagulopathy induced by traumatic brain injury:systemic manifestation of a localized injury[J].Blood, 2018, 131:2001-2006.
[13] Folkerson LE, Sloan D, Davis E, Kitagawa RS, Cotton BA, Holcomb JB, Tomasek JS, Wade CE. Coagulopathy as a predictor of mortality after penetrating traumatic brain injury[J]. Am J Emerg Med, 2018, 36:38-42.
[14] Lustenberger T, Talving P, Kobayashi L, Barmparas G, Inaba K, Lam L, Branco BC, Demetriades D. Early coagulopathy after isolated severe traumatic brain injury:relationship with hypoperfusion challenged[J]. J Trauma, 2010, 69:1410-1414.
[15] Jiang DP, Zhou JH. Posttraumatic coagulopathy:mechanism and clinical management[J]. Zhongguo Shi Yong Wai Ke Za Zhi, 2012, 32:907-910.[蒋东坡, 周继红. 创伤后凝血功能障碍机制及临床对策[J]. 中国实用外科杂志, 2012, 32:907-910.]
[16] McQuilten ZK, Bailey M, Cameron PA, Stanworth SJ, Venardos K, Wood EM, Cooper DJ. Fibrinogen concentration and use of fibrinogen supplementation with cryoprecipitate in patients with critical bleeding receiving massive transfusion:a bi-national cohort study[J]. Br J Haematol, 2017, 179:131-141.
[17] Yanagawa Y, Ishikawa K, Jitsuiki K, Yoshizawa T, Oode Y, Omori K, Ohsaka H. Fibrinogen degradation product levels on arrival for trauma patients requiring a transfusion even without head injury[J]. World J Emerg Med, 2017, 8:106-109.
[18] Zhang J, He M, Song Y, Xu J. Prognostic role of D-dimer level upon admission in patients with traumatic brain injury[J].Medicine (Baltimor), 2018, 97:e11774.
[19] Lee DH, Lee BK, Noh SM, Cho YS. High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma[J]. Eur J Trauma Emerg Surg, 2018, 44:291-298.
[20] Albert V, Arulselvi S, Agrawal D, Pati HP, Pandey RM. Early posttraumatic changes in coagulation and fibrinolysis systems in isolated severe traumatic brain injury patients and its influence on immediate outcome[J]. Hematol Oncol Stem Cell Ther, 2019, 12:32-43.
[21] Wang X, Hou LJ. Pathogenesis of traumatic brain injury -associated coagulopathy:a review[J]. Di Er Jun Yi Da Xue Xue Bao, 2013, 34:72-77.[王向, 侯立军. 颅脑创伤相关性凝血障碍发病机制[J]. 第二军医大学学报, 2013, 34:72-77.]
[22] Hayakawa M, Maekawa K, Kushimoto S, Kato H, Sasaki J, Ogura H, Matauoka T, Uejima T, Morimura N, Ishikura H, Hagiwara A, Takeda M, Kaneko N, Saitoh D, Kudo D, Kanemura T, Shibusawa T, Furugori S, Nakamura Y, Shiraishi A, Murata K, Mayama G, Yaguchi A, Kim S, Takasu O, Nishiyama K. High D-dimer levels predict a poor outcome in patients with severe trauma, even with high fibrinogen levels on arrival[J]. Shock, 2016, 45:308-314.
[23] Ye YZ, Wang ZX. Progress of coagulation disorder after brain injury[J]. Zhonghua Shen Jing Wai Ke Ji Bing Yan Jiu Za Zhi, 2012, 11:85-87.[叶永造, 王占祥. 颅脑损伤后凝血障碍研究进展[J]. 中华神经外科疾病研究杂志, 2012, 11:85-87.] |